ReviewCancers2022

Combination of Anti-Angiogenics and Checkpoint Inhibitors for Renal Cell Carcinoma: Is the Whole Greater Than the Sum of Its Parts?

Eric Jonasch et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.